SEC Form 4 research
| Issuer | NEKTAR THERAPEUTICS |
|---|---|
| Tickers | NKTR |
| Reporting owners | 42 |
| Officers and directors | 18 |
| Last public filing | 2026-09-26 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-25 | 2026-09-23 | WHITFIELD ROY A | A | 2,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | WHITFIELD ROY A | A | 4,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | GREER R SCOTT | A | 2,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | GREER R SCOTT | A | 4,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | CHESS ROBERT | A | 2,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | CHESS ROBERT | A | 4,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Brainard Diana | A | 2,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Brainard Diana | A | 4,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Ajer Jeffrey Robert | A | 2,000 | $0 | Not reported |
| 2026-09-25 | 2026-09-23 | Ajer Jeffrey Robert | A | 4,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.